Equillium to attend Jefferies_Group conference
Analysis based on 6 articles · First reported May 28, 2026 · Last updated May 28, 2026
The participation of Equillium>>> in the Jefferies>>> Global Healthcare Conference provides an opportunity for investors to learn more about the company's therapies, potentially influencing its stock performance. This event offers a platform for Equillium>>> to enhance its visibility and attract investment.
Equillium>>>, a biotechnology company focused on autoimmune and inflammatory disorders, announced its participation in a fireside chat at the 2026 Jefferies>>> Global Healthcare Conference. The event is scheduled for Wednesday, June 3, 2026, at 4:55pm EDT. Equillium>>>'s management team will also be available for meetings with registered investors, aiming to highlight their novel therapies and engage with the financial community.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard